More than a third of a century has elapsed since the publication of the first in vivo MRI study of multiple sclerosis (MS) lesions, a period during which the identification of such lesions has become our single most important diagnostic test for MS. Remarkably, the in-depth study of MS lesions by means of contemporary imaging techniques continues to uncover fundamental aspects of the pathophysiology of the disease 1 . Multimodal imaging at high and ultra-high magnetic field strengths has yielded biologically relevant insights into lesion structure and blood-brain barrier (BBB) dynamics that are gradually narrowing the gap between the macroscopic view of the radiologist and the microscopic view of the pathologist.
More than a third of a century has elapsed since the publication of the first in vivo MRI study of multiple sclerosis (MS) lesions, a period during which the identification of such lesions has become our single most important diagnostic test for MS. Remarkably, the in-depth study of MS lesions by means of contemporary imaging techniques continues to uncover fundamental aspects of the pathophysiology of the disease 1 . Multimodal imaging at high and ultra-high magnetic field strengths has yielded biologically relevant insights into lesion structure and blood-brain barrier (BBB) dynamics that are gradually narrowing the gap between the macroscopic view of the radiologist and the microscopic view of the pathologist.
In this Review, we explore how imaging findings can mirror the pathological development of the demyelinated MS lesion. We describe the patterns by which gadolinium leaks into the parenchyma, either centrifugally (outward from the central vein) or centripetally (inward from the lesion edge), highlighting the dynamism of the BBB in veins and capillaries as it responds to inflammatory stimuli. The introduction of ultra-high-field 7 T human MRI scanners, and of MRI techniques that are highly sensitive to paramagnetic substances, has enabled visualization of prominent central veins within most demyelinated MS lesions, and of paramagnetic rims at the lesion margin in some cases. We also review progress in the imaging of demyelination and remyelination.
Throughout this article, we parallel the results in humans with recent advances in 7 T imaging of a primate model of MS, experimental autoimmune encephalomyelitis (EAE) in the common marmoset. The demyelinated brain and spinal cord lesions resemble the human counterpart far better in this model than in the rodent EAE model 2 . Animal models offer the possibility to image at baseline and frequently after disease induction, thereby enabling investigation of early, subtle radiological changes within normal brain tissue before lesion formation 3 . Another important advantage of animal models is that the pathology underlying the MRI findings can be accessed once the experiment is ended. Lesions in the marmoset brain are often small, so high-resolution (≤100 µm isotropic voxels) scans of the fixed brain, performed before processing of the tissue for histology, can be very useful (FIG. 1) . Customized 3D-printed tissue holders and slicers facilitate matching of the histopathology with MRI, which greatly improves the interpretability of the data 4 . This technology, combined with serial MRI scanning before and after lesion development, can elucidate the cellular basis of development and repair of EAE lesions and, by extension, the histopathologically similar lesions in MS itself.
Taken together, the advances described in this article hold considerable promise for deepening our understanding of the biology of MS while opening up the possibility of next-generation proof-of-concept clinical trials mainly focused on tissue protection and repair.
Early development of MS lesions
Immunopathology. Breakdown of immunological tolerance to CNS myelin or myelin-like antigens is generally accepted to be the basis of MS pathogenesis. Routes of Abstract | Over the past few decades, MRI-based visualization of demyelinated CNS lesions has become pivotal to the diagnosis and monitoring of multiple sclerosis (MS). In this Review, we outline current efforts to correlate imaging findings with the pathology of lesion development in MS, and the pitfalls that are being encountered in this research. Multimodal imaging at high and ultra-high magnetic field strengths is yielding biologically relevant insights into the pathophysiology of blood-brain barrier dynamics and both active and chronic inflammation, as well as mechanisms of lesion healing and remyelination. Here, we parallel the results in humans with advances in imaging of a primate model of MS -experimental autoimmune encephalomyelitis (EAE) in the common marmoset -in which demyelinated lesions resemble their human counterparts far more closely than do EAE lesions in the rodent. This approach holds promise for the identification of innovative biological markers, and for next-generation clinical trials that will focus more on tissue protection and repair.
physiological immune surveillance have been recognized to be involved early in the pathogenesis of both MS and EAE. Peripheral lymphocytes undergo trafficking, participate in immune surveillance and interact with CNS-resident antigen-presenting cells in the meninges (at the blood-leptomeningeal barrier), along ventricular ependymal surfaces (blood-choroid plexus barrier), within perivascular spaces (BBB), and in cervical lymph nodes 5 . Once they escape peripheral tolerance, autoreactive lymphocytes can be further activated and become hostile effectors (CD8 + , CD4
+ T-helper 1 (T H 1), CD4
+ T H 17 and B lymphocytes) 6 , thereby precipitating demyelination and axonal injury, which are the typical features of MS.
In early disease, the most dramatic immunopathological events leading to focal areas of demyelination -the 'lesion' of MS -tend to occur at the level of the BBB in small or medium-size parenchymal veins, although early subpial cortical demyelination has also been recognized 7 
.
As they follow the venous vasculature, demyelinated MS lesions are commonly found around the ventricles (deep venous system, subependymal and medullary veins), at the grey-white matter junction (superficial venous system, especially cortical veins), within the optic nerve (branches of the central retinal vein), and in the brainstem (anteriorly and transversely oriented deep veins) and spinal cord (often posterior deep spinal veins). The spatial predilection and timing of a particular vein's involvement remain fascinating research topics. In general, however, the process of rapid demyelination, which progressively spreads from and along a prominent parenchymal vein to involve the surrounding tissue, directly influences the macrostructure and shape (ovoid, ellipsoidal, triangular or U-shaped) of MS lesions (FIG. 2) .
Human imaging. As demyelinated lesions in the brain and spinal cord are easy to detect on long echo-time MRI pulse sequences, such as T2-weighted and T2-fluidattenuated inversion recovery (FLAIR) sequences, these techniques have been implemented in everyday clinical practice and are integral to current MS diagnostic criteria 8, 9 . Though recognized in pathological studies as early as the ninteenth century 10 , the perivenular topography of MS lesion development has only recently been directly visualized in vivo, using high-resolution susceptibility-sensitive imaging at a variety of magnetic field strengths (see Supplementary information S1 (video)) [11] [12] [13] [14] [15] [16] [17] [18] . The reasons for the characteristic prominence of the central vein within MS demyelinated lesions in comparison to surrounding brain parenchyma are still open to debate, and include an elevated concentration of deoxyhaemoglobin (higher oxygen extraction at the site of inflammation) and changes in vessel diameter (slower venous flow, postinflammatory scarring processes of the vein wall) [19] [20] [21] . Far from being a mere morphological feature of MS lesions, the 'central vein sign' has potential relevance for the diagnostic work-up 9, 22 , as it is consistently described as atypical in small vessel disease 15, 16, 23, 24 and migraine 25 , and is rarely observed in other immunological conditions associated with brain lesions (for example, vasculitis and neuromyelitis optica spectrum disorder) 26 . Studies conducted in large populations will be required to ascertain the true positive predictive value of the central vein sign.
Marmoset imaging.
Various EAE immunization protocols have been described in marmosets [27] [28] [29] [30] , but in this Review we will focus primarily on disease induced by subcutaneous injection of human white matter homogenate with an adjuvant 3, 27 , which in our hands produces a disease that bears strong similarities to relapsing-remitting MS. As in MS, MRI can detect demyelinated lesions that form in the CNS of marmosets with EAE [31] [32] [33] . EAE lesions in the marmoset brain present with similar features to MS lesions, including distribution throughout the CNS with a preferred location in the subcortical white matter 3, 34, 35 , uptake of gadolinium contrast agent 3, 36 , and perivenular topography 37 ( FIG. 1) . Interestingly, the veins around which most of the lesions form are already visible on scans before disease induction, supporting the notion that the inflammation associated with EAE affects previously normal veins. These superficial medullary veins drain the white matter lesions and pass through the cortex into the subarachnoid space. The close relationship between these veins and cerebrospinal fluid within their perivascular spaces is likely to have an important role in lesion development.
Before abrupt opening of the BBB Immunopathology. A prevalent adaptive immune response to myelin-like antigens triggers an aggressive, scavenger-type response of the innate immune system against CNS myelin. This response is characterized by a classic triad: first, dramatic opening of the BBB; second, blood-derived inflammatory cell (monocytemacrophage) invasion; and third, macrophage-mediated stripping of myelin sheaths from axons 38, 39 . The temporal sequence of the earliest pathological events has not been completely unravelled, and remains a subject of active investigation in animal studies. Perivascular inflammatory cuffing is the most prominent pathological feature associated with the newly forming lesion, and is characterized by aggregates of lymphocytes and monocytes confined within the perivascular space of the postcapillary venule and not yet breaching the glia limitans of the BBB (parenchymal basement membrane and 40 ; parenchymal microglial and astrocytic activation; perivascular swollen or apoptotic oligodendrocytes with still-intact myelin (the so-called prephagocytic or (p)reactive lesion) 41, 42 ; and early axonal and synaptic dysfunction 38, 39, 43, 44 .
Human imaging. The early pathological findings in both MS and EAE are consistent with the in vivo detection of subtle radiological changes in the normal-appearing white matter days to weeks before the parenchymal gadolinium enhancement that defines the radiological onset of the impending MS lesion [45] [46] [47] [48] [49] [50] [51] [52] . These data, derived mostly from quantitative or semiquantitative MRI studies that are pathologically nonspecific and only statistically significant at the group level, support the concept of a short-term temporal dissociation between the earliest immunological events in lesion development and the dramatic opening of the BBB (captured on MRI as parenchymal leakage of gadolinium) and subsequent demyelination. Recently, taking advantage of high-resolution imaging and frequent scanning, we have directly visualized focal alterations of MRI signal, on T2-FLAIR and T2*-weighted images, around the central vein of the future MS lesion 18 . Specifically, in some cases, before the overt onset of the radiologically defined demyelinated lesion, the 'inflamed' central vein enhances in isolation, perhaps owing to higher BBB permeability with entrapment of the contrast agent within the perivascular space 18 .
Marmoset imaging. In a study published in 2014 (REF. 3 ), we monitored the status of BBB permeability by mapping the longitudinal relaxation time ('T1') before and after injection of a triple dose of gadolinium-based MRI contrast agent. We performed weekly MRI scans, including T1 mapping, as well as proton density-weighted and T2-weighted imaging, after induction of EAE in marmosets. We showed that the BBB becomes focally and increasingly permeable starting approximately 4 weeks before lesion appearance. We also demonstrated that areas of abnormal BBB permeability observed at the time of sacrifice corresponded to inflammatory nodules without associated demyelination. Those nodules consisted of small clusters of perivascular and parenchymal, Iba1-positive, activated microglia and macrophages in association with variable numbers of perivascular lymphocytes. Our results suggest that early changes in vascular permeability, associated with perivascular inflammatory cuffing and parenchymal microglial activation, might precede the formation of new lesions.
BBB dynamics in early MS lesions
Immunopathology. The BBB is recognized to be a highly organized structure, composed of endothelial cells, pericytes and astrocytic end-feet, all of which partially isolate the peripheral blood circulation from the CNS parenchyma 53 . The endothelial and parenchymal basement membranes, consisting of collagen IV, fibronectin and laminin, enclose the 'perivascular' space, in which -as stated above -normal and pathological immune surveillance takes place. In early MS lesions, autoreactive and activated lymphocytes directly contribute to impairment of the BBB of the postcapillary venules, characterized initially by moderately increased permeability and eventually by dramatic structural disruption 38, 39, 44, 54 . Activated CD4 + lymphocytes can secrete the cytokines IFN-γ and tumour necrosis factor (TNF), which upregulate endothelial adhesion molecules (VCAM1 and α1 integrin) and chemokines, thereby inducing massive recruitment of monocytes and allowing transendothelial migration of these cells into the perivascular space and, subsequently, the parenchyma. Structural disruption of the BBB is mediated by the secretion of matrix Nature Reviews | Neurology metalloproteinases that can damage endothelial tight junctions and basement membranes, causing leakage of serum proteins and water (vasogenic oedema) into the white matter 55, 56 . Impaired breakdown of leaking fibrinogen, and its breakdown product fibrin, might also contribute to the inflammatory demyelinating cascade 57, 58 . This highly inflammatory environment eventually leads to disorganization of the BBB's outer shell (the astrocytic end-feet that comprise the glia limitans).
Human imaging. The striking radiological appearance of newly forming MS lesions is commonly accepted to be related to leakage into the parenchyma (and, therefore, visualization on T1-weighted images) of intravenously injected contrast agents, which are usually gadoliniumbased 59, 60 . This leakage reflects the short-term structural opening of the BBB -specifically, damage to tight junctions and basement membranes -that occurs at lesion onset.
Dynamic contrast-enhanced MRI (DCE-MRI) at high magnetic field strength is a technique in which T1-weighted images are quickly acquired before, during and at various time points after gadolinium injection. Through use of this technique, the spatiotemporal dynamics of BBB opening in active MS lesions can be dissected in vivo, thereby providing complementary insights to the immunopathological studies. In this dynamic view, in essentially all early active demyelinating lesions, gadolinium leaks initially from the central vein and flows outward, filling the lesion within a few minutes. On static images acquired 5-10 min after contrast injection -the typical situation in clinical practice Nature Reviews | Neurology Of note, the shape of MS lesions can be also affected by the macrostructure of the surrounding tissue. For example, both the ependymal wall of the ventricles and the cortex may act as barriers to the spread of myelin-scavenging inflammatory cells. Depending on the trajectory of the vein and its position relative to these structures, lesions might assume a triangular shape, for periventricular and leukocortical-juxtacortical lesions, or a U shape, for leukocortical-juxtacortical lesions. The lower panel shows the various types of cortical demyelination. In addition to vasculocentric demyelination, which occurs in purely intracortical and leukocortical lesions, plaque-like demyelination can affect the subpial layers of the cortex and is thought to be directly triggered by leptomeningeal inflammation. MS, multiple sclerosis; t, time point.
-such lesions would be characterized as having 'nodular' enhancement. From a dynamic point of view, this process has been termed centrifugal (outward) contrast enhancement 61, 62 . After a few days to a few weeks, many of the larger lesions exhibit a shift in the pattern of gadolinium enhancement. In such cases, the expanding inflammatory edge enhances first, and gadolinium then flows centripetally (inward) toward the demyelinated lesion centre 17, 61, 62 (see Supplementary information S2,S3 (videos)). When this shift occurs, the appearance of the lesion on static images might be either a nodule or a ring, depending on several factors. Especially important among these factors is the time elapsed between contrast injection and MRI acquisition, but the location of the lesion is also important in determining whether the ring is complete or open: an open ring is typically seen when the lesion abuts grey matter or the ventricles. Centrifugal enhancement clearly supports the centrality of perivenular pathogenic events at lesion onset. The significance of centripetal enhancement is less certain, and we hypothesize that this feature might be part of the physiological -though detrimental if unrestrained -wound-healing inflammatory reaction of the CNS parenchyma to focal demyelination.
Marmoset imaging.
The dramatic opening of the BBB can also be visualized in active EAE lesions, using T1-weighted images obtained after intravenous injection of gadolinium-based contrast agents. Like MS lesions, active EAE lesions usually display nodular enhancement on static postcontrast T1-weighted images. To our knowledge, open-ring enhancement has not been reported in marmoset EAE. The spatiotemporal dynamics of the gadolinium leakage in active EAE lesions have not yet been fully characterized, mainly due to the limi tations imposed by the smaller dimensions of EAE lesions and the higher cardiac output of marmosets compared with humans. Nonetheless, a recent quantitative MRI study has provided some insights into the dynamics of BBB leakage over the span of a few weeks 3 . Following a gradual increase in permeability that occurs early in lesion development, the BBB reaches its maximum permeability once the lesion becomes visible on all types of images (T1-weighted, T2-weighted, T2*-weighted and proton density-weighted, as well as T2-FLAIR). After the lesion appears, the permeability of the BBB gradually decreases back to near-normal levels, signifying a restored BBB, in approximately 2-4 weeks 3 .
Macrophage-mediated demyelination
Immunopathology. Stripping of myelin from axons and phagocytosis of myelin debris are mediated by blood-derived macrophages and activated CNSresident microglia, which together constitute the prevalent cellular population within the active demyelinating lesion 38, [63] [64] [65] . These cell types are difficult to distinguish even at the tissue level (although progress has recently been made on this front 66 ), and here we will use the term 'macrophage' for simplicity.
The proinflammatory status of macrophages probably contributes to further tissue damage via free radical formation and secretion of proteases and cytokines, including IFN-γ and TNF. Macrophages track the spatiotemporal pattern of BBB opening and demyelination described above. Thus, they initially distribute throughout the lesion, starting from the centre, and they subsequently become more concentrated at the lesion margin (so-called 'late active' lesions). Interestingly, the efficiency by which macrophages clear myelin debris seems to decrease with age 67 . In addition, in an attempt to limit amplification of oxidative stress and mitochondrial energy failure during early lesion development, an excess of free iron, probably released from oligodendrocytes during the process of demyelination and/or mediated by endothelial transferrin receptor upregulation, is buffered, mainly by macrophages and astrocytes [68] [69] [70] . Persistently demyelinated axons are more prone to degenerate in an inflammatory environment 71, 72 , which might explain the varying degrees of axonal injury and loss that coexist with demyelination in MS lesions.
Human imaging.
A persistent issue in imaging of MS lesions in vivo is related to the fact that inflammation, demyelination and axonal loss within lesions are not cleanly distinguishable on T2-weighted and T1-weighted images. This lack of specificity has prompted a number of attempts to develop MRI approaches that are more pathologically interpretable, such as quantification of the short T2 component in multi-echo T2 relaxation experiments, which seems to correlate with water selectively enclosed between myelin bilayers (so-called 'myelin water imaging') [73] [74] [75] [76] .
Complementary work on the spatiotemporal dynamics of the BBB has shown that the front of demyelination and inflammation can be captured by coupling DCE-MRI with susceptibility-based MRI at 7 T (REF. 17) . These experiments have shown that in centripetally enhancing lesions, the initial opening of the BBB at the lesion edge clearly colocalizes with a paramagnetic rim on phase images -a novel endogenous marker of inflammation 17 
(see Supplementary information S2 (video) and FIG. 3).
Other investigations showed that on 3 T phase images, visualization of phase MRI changes was better overall in young lesions in early disease than in older lesions 51, [77] [78] [79] . Pathological features of the younger lesions that might explain this observation include more-prominent demyelination in comparison to axonal loss, and high inflammatory activity with attendant paramagnetic substances, such as free radicals and iron.
Marmoset imaging. By combining serial conventional imaging and histopathology, we have demonstrated that <1-week-old EAE lesions surround a central inflamed blood vessel that is cuffed with T cells and macrophages 3 . Perivascular B cells and blood-derived MRP14 + early activated macrophages are also observed, albeit less frequently than T cells and MRP14 − macrophages, and macrophage-microglia-associated demyelination and disrupted axons are seen throughout the lesion. Lesions 1-5 weeks old continue to enlarge, and active demyelination is observed at the lesion edges. Interestingly, early activated macrophages are only found at the leading edge of demyelination 3 . Conventional MRI lacks specificity toward tissue pathology in EAE lesions, as in MS lesions, and inflammation, demyelination and axonal loss cannot be differentiated in vivo 31 . In one study, quantitative MRI findings correlated with macrophage infiltration, but demyelination was a potential confounder 33 . Recently, an advanced MRI technique, based on complex analysis of the T2* decay curve, was used for in vivo detection of the myelin water content in white matter of healthy marmosets 75 . However, the application of this technique to track demyelination and remyelination remains challenging, as T2* decay curves can be strongly affected by oedema in the extracellular space, iron accumulation in macrophages, and the orientation of white matter tracts relative to the magnetic field of the MRI system. To date, a paramagnetic rim on phase images has not been observed in marmoset EAE lesions, and whether this is due to lack of sensitivity of the applied MRI techniques or to biological differences remains uncertain.
Lesion evolution after BBB restoration
Immunopathology. The processes of BBB closure and resolution of inflammation are recognized as potential sources of new therapeutic targets in MS, but the underlying mechanisms have not been completely unravelled. An emerging idea is that inflammation in MS, while clearly driving demyelination and tissue destruction, can also trigger healing, albeit dysregulated and, hence, either incomplete or ineffective. In this context, an analogy has been drawn between extra-CNS wound healing and the process of repair within MS lesions 80 . The initiation of healing seems to reside in the extreme plasticity of macrophages, the functional phenotypes of which run the gamut from destructive ('classically activated') to restorative ('alternatively activated') in the face of environmental stimuli that may vary over time. In the realm of remyelination [81] [82] [83] [84] [85] , recent data indicate that in early lesions, classically activated macrophages (sometimes called 'proinflammatory' macrophages) can induce the recruitment of oligodendrocyte precursors, whereas alternative ('anti-inflammatory') activation is required for differentiation of these precursor cells Nature Reviews | Neurology Supplementary information S2 (video)), appears adjacent to lesion A at month 6. Both lesions exhibit a central vein on T2*-weighted magnitude and phase images. In lesion B, the peripheral T2*-weighted magnitude and phase rim persists after resolution of contrast enhancement (1 and 6 months after lesion onset). Of note, lesion B shrinks over time after enhancement resolves, whereas lesion A nearly triples in size, even in the absence of visible contrast enhancement on postcontrast T1-weighted images. By month 12, the persistent T2*-weighted magnitude and phase rims in both lesions have become darker and thicker, suggesting accrual of paramagnetic substances at the lesion edge. Pathologically, the rim possibly results from macrophages loaded with iron, and lesions with this radiological feature might, therefore, correspond to the so-called 'chronic active' or 'smouldering' lesions. MS, multiple sclerosis.
into myelinating oligodendrocytes 67 . Remyelination remains the subject of extensive investigations that are outside the scope of this Review [84] [85] [86] [87] [88] [89] . Human imaging. After the resolution of gadolinium enhancement, usually 2-8 weeks following its emergence, MS lesions are radiologically defined as 'chronic' . The lesions remain clearly visible on both T2-weighted and T1-weighted images, and the extent of T1 hypointensity seems to correlate with axonal degeneration in the white matter 90, 91 . Unfortunately, as discussed above, clinical MRI sequences are unable to directly image remyelination. After oedema resolves, typically 1-3 months after lesion onset, tracking of longitudinal signal intensity on T1-weighted, T2-weighted, proton density-weighted and magnetization transfer-weighted sequences, as well as through lesion volume measurement, remains the established strategy to assess short-term lesion repair 92, 93 .
Marmoset imaging. The subacute EAE lesions described above show a decrease in BBB permeability in their core area over approximately 4 weeks 3 . By 5 weeks, the lesions display markedly reduced BBB permeability and inflammation, and the macrophages disappear. These lesions are still visible on MRI but become smaller over time -a finding that is consistent not only with a reduction in inflammation but also with potential repair, including remyelination. As most marmoset experiments end within weeks to months of lesion development, the natural history and pathology of chronic lesions has not been extensively studied, and is an enticing topic for future research.
Smouldering inflammation
Immunopathology. On histological sections, chronic lesions appear hypocellular and demyelinated, with a varying degree of axonal loss. However, an inflammatory infiltrate, wherein macrophages and activated microglia contain early or late myelin degradation products, characterizes the margins of a variable percentage (20-40%) of demyelinated lesions (variously termed 'chronic active' , 'slowly expanding' , or 'smouldering') 63, 64, 68, 94, 95 . On the basis of autopsy studies, this lesion category is especially common in people at the transition to clinically progressive disease and those with long disease duration, supporting the notion that these lesions contribute to long-term and clinically important tissue damage 68, 94, 95 .
Human imaging. Chronic inflammation is trapped behind an intact BBB and, hence, remains invisible to current gadolinium-based MRI. Through the use of highresolution, noncontrast, susceptibility-based imaging, a paramagnetic rim has recently been detected at the margin of some nonenhancing MS lesions. Initial MRI-pathology investigations suggested that this radiological finding might aid identification of chronic active/smouldering lesions in vivo. Steady accumulation of macrophages at the lesion edge, in association with paramagnetic inflammatory species related to free radical production and/or intracellular iron accumulation, might explain the paramagnetic signal observed in vivo 12, 17, 78, [96] [97] [98] [99] [100] (FIG. 3) .
In the context of early lesion evolution, the subset of centripetally enhancing lesions with a phase rim that persists after the closure of the BBB tend to exhibit poor lesion recovery in terms of lesion volume and T1 hypo intensity at year 1, suggesting impairment of early repair and/or permanent tissue injury 101 (FIG. 3) . If confirmed, this feature will constitute a valuable imaging biomarker, not only to better stage MS lesions in vivo, but also to uncover specific components of MS-related hidden inflammation. Similarly, peripheral macrophages experimentally labelled with ultrasmall superparamagnetic iron oxide particles (USPIO) have been tracked at the edges of demyelinated lesions with an apparently intact BBB (that is, lesions with no observable leakage of traditional gadolinium-based contrast agents) [102] [103] [104] . A direct comparison between USPIO-based and susceptibility-based imaging is currently lacking.
Marmoset imaging. Bert 't Hart and colleagues applied conventional imaging (T2-weighted and T1-weighted with gadolinium injection) to a group of marmosets reaching the chronic stage of EAE disease 31 . Among the chronic lesions, late active demyelinating lesions (with macrophages containing myelin proteolipid protein degradation products located at the edge) were observed together with inactive demyelinated and remyelinated lesions, as confirmed using histopathology 31 . However, the MRI scans performed in this study could not differentiate these chronic active lesions from their inactive counterparts. USPIO-based MRI, which has been successful in detecting infiltrated macrophages in rodent EAE [105] [106] [107] , could prove useful for identifying chronic active lesions in marmoset EAE. Another approach would be to perform serial susceptibility-based imaging to detect phase rims in those chronic lesions. These strategies represent exciting targets for future research.
Caveat
Four different initial immunological patterns are associated with acute myelin damage and BBB opening, supporting the idea that MS is a collection of different pathophysiological entities 40, 108, 109 . What has been described in this Review -the staging of white matter MS lesions and its MRI correlates -probably refers to immunological patterns I and II (myelinautoimmune hypothesis), which together are the most common types of active MS lesions 40 . No imaging correlate has yet been shown to definitively identify lesions with immunological pattern III, in which the prime mover is thought to be toxic and/or hypoxic injury to mature oligodendrocytes 40 .
Cortical and leptomeningeal involvement
Immunopathology. Cortical and leptomeningeal involvement has recently been recognized as a key feature in MS pathogenesis (early disease with clinical relapses and remission) 7, 110 and related neurodegeneration (thought to be largely responsible for clinical progression) 111 . Like the white matter, the cortex can display demyelination, but with much less pronounced inflammation and, importantly, without abrupt opening of the BBB 7, [112] [113] [114] . Remyelination may be enhanced within the cortex in comparison with the white matter 84, 115 . Topographically, cortical lesions develop along the pial surface ('subpial lesions') or around cortical venules that drain into the subarachnoid space (small intracortical and leukocortical demyelinated lesions) 112, 116 (FIG. 2) . This topography supports the hypothesis that lepto meningeal inflammation, involving effector lymphocytes, cytotoxic diffusible mediators and immunoglobulins, is strictly related to cortical lesion development via direct damage of the subpial layers of the cortex and/or inflammation spreading into the parenchyma 7 . Subpial cortical demyelination has been characterized as specific to MS-related pathological processes 117 . Of note, aggregates of lymphocytes resembling lymphoid follicles have been recognized in the leptomeninges in patients with progressive MS, and have been judged to reflect an extreme form of compartmentalized, long-lasting inflammation 7, [118] [119] [120] [121] [122] [123] . The interplay among leptomeningeal inflammation, cortical demyelination and neurodegeneration, as well as more generally between tissue damage in white and grey matter, is still under investigation 111, 124, 125 .
Human imaging. Cortical lesions have been reported
in vivo at all stages of MS (though more frequently in progressive MS), but subsequent autopsy findings indicate that their numbers are profoundly underestimated on MRI [126] [127] [128] . Of note, cortical lesions do not enhance after gadolinium administration, which at present precludes their staging in vivo. Double inversion recovery 126 , phase-sensitive inversion recovery 129 , and high-resolution T2*-weighted [130] [131] [132] and magnetizationtransfer-weighted sequences 133, 134 can detect some of these lesions, especially those with transcortical involvement and/or demyelination of the underlying white matter ('leukocortical lesions'). Subpial demyelin ation (affecting only the superficial cortical layers) and small intracortical lesions have been visualized more reliably on high-resolution postmortem images (FIG. 4) , but are only sporadically reported in vivo [130] [131] [132] . Cortical demyelination shows positive correlations with disability and cognitive impairment scores, thereby underlining the clinical importance of improved detection of this feature 131, [135] [136] [137] [138] [139] . Together with periventricular, infratentorial, spinal cord and optic nerve lesions, cortical/ juxtacortical lesions contribute to the recently proposed revised 'dissemination in space' MRI criteria for the diagnosis of MS 9 . With respect to leptomeningeal inflammation, a recent study, in which in vivo and postmortem MRI findings were correlated with pathology, reported the prevalence of subarachnoid-space abnormalities in a cohort of ~300 people with MS on both 3 T and 7 T post contrast T2-FLAIR images 140 . Spatially confined disruption of the blood-leptomeningeal barrier, manifesting as foci of gadolinium enhancement, was identified in ~35% of individuals with progressive MS and ~25% of all patients studied (FIG. 4) . The presence of leptomeningeal enhancement correlated with whole-brain and cortical atrophy 140 . In autopsy cases, these foci colocalized with peri vascular inflammatory infiltrates -specifically, lymphocytes and macrophages clustered around leptomeningeal vessels and along intracortical perivascular spaces -and adjacent subpial cortical demyelination 140 . Nature Reviews | Neurology a b Marmoset imaging. Demyelinated cortical lesions similar to those in MS (leukocortical, intracortical and subpial) are known to affect the marmoset EAE brain, as shown in several histopathological studies [141] [142] [143] [144] . Clusters of T lymphocytes and plasma cells have recently been observed in the meninges overlying subpial cortical demyelination 145 , suggesting that local meningeal lymphocytic and plasma cell infiltration also contributes to the pathogenesis of subpial demyelination in marmoset EAE. However, in vivo MRI visualization of cortical demyelination and meningeal inflammation has not yet been reported in this animal model.
Conclusions
In this Review, we have summarized recent research efforts to narrow the gap between pathology and imaging in MS lesion development and staging. We have also presented parallel efforts in marmoset EAE, an animal model bearing strong immunological, pathological and radiological similarities to MS. In marmoset EAE, the pathological basis of developing and repairing lesions can be investigated using a combination of serial in vivo MRI imaging and histology, and the results of these investigations have strong relevance for our understanding of similar processes in MS. Some observations from human imaging, such as open-ring enhancement, phase rims, meningeal enhancement and cortical lesions, have not been consistently reported in marmoset EAE, and certain observations from marmoset imaging, such as consistently increased permeability of the BBB in the weeks preceding focal demyelination, have not been described in humans. These differences may be attributable in large part to technical factors, but biology could also contribute.
The parallels reviewed here suggest that the combination of human MS and marmoset EAE research is a promising pathway to achieve a deeper understanding of the pathobiology of BBB dynamics, chronic inflammation, and mechanisms of repair and remyelination, together with the development of new MRI techniques to detect and monitor their evolution in vivo. The ability to image both marmosets and humans at the same field strength (7 T) enables ready investigation and translation of new MRI markers from bench to bedside, and vice versa. Finally, this unique approach holds promise for the identification of novel biological targets and next-generation clinical trials that will focus on tissue protection and repair -a major unmet need in MS.
